TrialIndian heart journal

Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study.

Balbir Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.